Showing results (141-150 of 202) with videos related to
Sort By:
Pageof 21
Familial Cancer|November 15, 2024
BRCAIndica: a resource for ACMG/AMP classified BRCA1 and BRCA2 variantsAastha Vatsyayan, R I Anu, Prerika Mathur, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2016
Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast CancerRekha Gyanchandani, Yan Lin, Hui-Min Lin, et al.Pain|January 8, 2013
Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without painKristin L Schreiber, Marc O Martel, Helen Shnol, et al.Trials|December 18, 2015
Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trialDenise A Yardley, Adam Brufsky, Robert E Coleman, et al.The Oncologist|February 12, 2020
De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs RegistryDebu Tripathy, Adam Brufsky, Melody Cobleigh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2018
Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERsSara A Hurvitz, Joyce O'Shaughnessy, Ginny Mason, et al.JCO Global Oncology|July 19, 2022
Cancer Medicines: What Is Essential and Affordable in India?Manju Sengar, Adam Fundytus, Wilma Hopman, et al.Cancer Investigation|January 12, 2005
Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trialRamesh K Ramanathan, Jimmy J Hwang, William C Zamboni, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 2, 2006
NCCN Task Force Report: Bone Health and Cancer CareRichard L Theriault, J Sybil Biermann, Elizabeth Brown, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Spontaneous CD4+ T cell responses against TRAG-3 in patients with melanoma and breast cancersBratislav Janjic, Pedro Andrade, Xiao-Fei Wang, et al.Pageof 21